Details
Stereochemistry | RACEMIC |
Molecular Formula | C13H29N.H3NO3S |
Molecular Weight | 296.47 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
NS(O)(=O)=O.CC(C)CCCC(C)NCCC(C)C
InChI
InChIKey=FDRZMEIDDOWJER-UHFFFAOYSA-N
InChI=1S/C13H29N.H3NO3S/c1-11(2)7-6-8-13(5)14-10-9-12(3)4;1-5(2,3)4/h11-14H,6-10H2,1-5H3;(H3,1,2,3,4)
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Octinum-D Approved UseAntispasmodic; for digestive, urinary tract and sphincter cramps, migraine headaches, urinary tract and hiccup, gastrointestinal tract equipment examination. For canker, cholecystitis, cholelithiasis diseases caused by abdominal pain, and the effect of atropine similar, but no other adverse reactions, dry mouth. |
Sample Use Guides
In Vivo Use Guide
Sources: http://chemyq.com/En/xz/xz12/119073rdaqo.htm
Oral: Each compound drops 25 to 40 drops
Route of Administration:
Oral
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
96296-56-9
Created by
admin on Sat Dec 16 08:10:43 GMT 2023 , Edited by admin on Sat Dec 16 08:10:43 GMT 2023
|
PRIMARY | |||
|
778333NHPO
Created by
admin on Sat Dec 16 08:10:43 GMT 2023 , Edited by admin on Sat Dec 16 08:10:43 GMT 2023
|
PRIMARY | |||
|
133065432
Created by
admin on Sat Dec 16 08:10:43 GMT 2023 , Edited by admin on Sat Dec 16 08:10:43 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD